Press Releases

Rho partners with TRI to provide centralized and risk-based quality management technology to their clients

Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that it has partnered with Triumph Research Intelligence (TRI), a global leader in centralized and risk-based quality management (RBQM) technology.

Creative Diagnostics Launches New ASFV Antigens and Antibodies for Research

Creative Diagnostics launches a large range of p30 antigens and antibodies for ASFV detection.

Signant Health finds growing eConsent adoption forecasts and the importance of eClinical integration in latest “State of eConsent” survey

Creative Enzymes Has Launched Enzyme Engineering and Modification Services to Accelerate Your Projects

KCR Announces New Chief Commercial Officer

Bryan Katz joins KCR’s growing executive team to take over as head of commercial strategy and global partnerships

Patient-Data Platform Raremark Enhances Executive Team to Accelerate Progress in Rare Disease Research

Raremark, the leading patient-data platform in rare disease, is pleased to announce additions to its executive team to speed the company’s pursuit of more treatments for rare medical conditions.

ERT Solutions Support 75% of 2019 FDA Approvals

eClinical solutions deliver critical safety, efficacy, and patient experience data to meet sponsors’ drug development goals

Certara Partners with Galderma in Advancing Modeling and Simulation Technology to Attain FDA Approval of AKLIEF® Topical Acne Cream

Certara's Simcyp® Simulator's MechDermA™ model provided safety label claim and pediatric dosing information without the need for testing in clinical patients for a topical drug product.

Signant Health Partners with Propeller Health to Gather Accurate Data on Asthma and COPD Medication Use

PHILADELPHIA, PENNSYLVANIA - Jan 7, 2020 - Signant Health announced today a partnership to connect TrialMax®, the industry-leading electronic Clinical Outcome Assessment (eCOA) platform, to Propeller Health’s digital health platform for asthma and COPD (chronic obstructive pulmonary disease)

4G Clinical Launches Innovative Clinical Supply Software Leveraging Natural Language Processing (NLP)

WELLESLEY, MA, UNITED STATES - Dec 19, 2019 - WELLESLEY, Mass., Dec. 19, 2019 /PRNewswire/ -- 4G Clinical today announced the launch of 4C Supply™, a cutting-edge clinical supply optimization software powered by Natural Language Processing (NLP)

KCR adopts Veeva Vault Clinical Suite

BOSTON - Dec 17, 2019 - KCR adopts Veeva Vault Clinical SuiteThe robust cloud platform will allow enhanced integration of trial management and documentation services through these new CTMS and eTMF solutions

Accumen Launches Healthcare Performance Publication

PHOENIX, AZ - Dec 16, 2019 - Accumen Inc., the leader in healthcare performance, has launched the Healthcare Performance Insider, a monthly publication and website, providing operational, clinical and data insights from across the healthcare industry

Signant Health Appoints Paul Drake as Chief Compliance and Security Officer

PHILADELPHIA, PA - Dec 17, 2019 - Signant Health, announced today that it has appointed Paul Drake, PhD, MSc, as Chief Compliance and Security Officer

MR Solutions participates in the first nanomedicine joint annual meeting in Dijon

GUILDFORD, UNITED KINGDOM - Dec 17, 2019 - UK based MR Solutions presented a simultaneous 7T PET/MRI preclinical imaging system optimized for nanoparticle imaging to the first joint annual congress of the French Nanomedicine Society (SFNano), and the French national Competency Cluster in Nanoscience C’Nano which was held in Dijon in early December

Spring Bank Announces Dosing of Patients in Phase 1 Clinical Trial of IV-Administered STING Agonist, SB 11285

HOPKINTON, MA, UNITED STATES - Nov 20, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that it has initiated dosing patients in a Phase 1 trial of SB 11285, the company’s intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist

BioIVT Announces the Launch of its Next-generation Sequencing Service

WESTBURY, NY - Dec 16, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today launched its Next-generation Sequencing (NGS) Service, which combines the company’s expertise in human tissue procurement, specimen selection, sample preparation and project management with its in-house NGS capabilities

Almac Group and Exostar Collaborate to offer Better IRT Experience

SOUDERTON, PA, UNITED STATES - Dec 13, 2019 - Almac Clinical Technologies,  a member of the Almac Group, has today announced the launch of a standardized, operationally-proven integration between its Interactive Response Technology (IRT) platform - IXRS® 3 and Exostar's Identity and Access Management Platform

TrialScope Engage™ Embedded Named a Most Innovative Healthcare Product of 2019

JERSEY CITY, NJ, UNITED STATES - Dec 13, 2019 - For the second year in a row, TrialScope, the global leader in clinical trial transparency, disclosure compliance and patient engagement technology solutions, has been recognized by PM360 for its forward-thinking innovation

Pistoia Alliance Report ‘Futurecasts’ a Decade of Change for Life Sciences and Healthcare

LONDON, UNITED KINGDOM - Dec 11, 2019 - The Pistoia Alliance, a global, not-for-profit organisation that works to lower barriers to innovation in life sciences R&D, today announced the publication of a new report into the future of the life science and healthcare industries: '2030: Life sciences and Health in the Digital Age'

MR Solutions installs the first 7T PET/MR integrated imaging system in Israel

GUILDFORD, UNITED KINGDOM - Dec 10, 2019 - MR Solutions has installed the first 7T PET/MR preclinical imaging system in Israel. The dry magnet system is helping to advance medical research at the Wohl Institute for Translational Medicine, part of the Hadassah Hebrew University Medical Center in Jerusalem